Cardioselective β1-adrenergic blocker. Oral form for hypertension; ophthalmic form (Betoptic) for glaucoma — preferred over timolol in patients with respiratory disease due to β1 selectivity reducing bronchospasm risk.
Half-Life & Elimination Curve (PO: 18h)
Plasma (PO)t½ Decay (18h)
0×t½0h100%(19.6 µg/L)
1×t½18h50%(9.78 µg/L)
2×t½36h25%(4.89 µg/L)
3×t½54h12.5%(2.44 µg/L)
4×t½3d6.3%(1.22 µg/L)
5×t½3.8d3.1%(0.611 µg/L)
Elimination t½18h (PO)
Rate Constant (ke)0.0385 h⁻¹
Time to Peak (Tmax)4.89h
Est. Peak (Cmax)19.6 µg/L
Clearance (CL)13.9 L/h
97% Washout (5×t½)3.8d
Dosing Guidelines
Oral (PO): Typical 10 mg (Range: 5–40 mg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 85% · Volume of Distribution (Vd): 360 L · Absorption (ka): 0.6 h⁻¹ (t½ka ≈ 1.16h) [PMID 2906367]